Schizophrenia drug for kids
On 22 August the US Food and Drug Administration approved risperidone – or Risperdal – for the treatment of schizophrenia in adolescents aged 13 to 17, and for the short-term treatment of bipolar disorder in children and adolescents aged 10 to 17. It is the first drug approved to treat schizophrenia in American adolescents. Risperidone is already approved for use in adults.
Gene therapy not to blame
A woman who died after being injected with a genetically modified virus to treat her arthritis suffered a massive fungal infection, suggesting that her immune system had been compromised. The finding…
